Actively Recruiting
Study of AI Technology to Support Blue Light Cystoscopy in Bladder Cancer Diagnosis
Led by Photocure · Updated on 2026-10-29
500
Participants Needed
12
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Blue light cystoscopy BLC is a diagnostic procedure used to observe the inside of the bladder and detect bladder lesions, especially in patients with bladder cancer. Unlike standard white light cystoscopy, BLC uses a drug that causes cancerous cells to fluoresce under blue light, improving lesion visualization. This study aims to collect data from BLC procedures to develop a computer-aided detection CADe algorithm to assist clinicians in real-time lesion detection during cystoscopy. The study collects high-quality videos, images, and clinical data from routine BLC procedures in adult patients undergoing this diagnostic process. The data will support training and technical development of AI algorithms, including those for lesion detection, diagnosis, image enhancement, bladder mapping, tumor visualization, and risk assessment. Participants undergo BLC as part of their usual clinical care, and the study records the procedure data to build a diverse dataset. Participants will have their BLC procedure recorded through video and images during a single day. The study involves no additional interventions beyond standard care. Researchers will use the collected data to train and test AI models and support future validation studies. The total participation time corresponds to the day of the BLC procedure when data collection occurs.
CONDITIONS
Brief Title
Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
Research Team
K
Kristine Young-Halvorsen, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here